| The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells K Maharaj, JJ Powers, A Achille, M Mediavilla-Varela, W Gamal, ... Blood Advances 4 (13), 3072-3084, 2020 | 64 | 2020 |
| Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability W Gamal, RH Fahmy, MI Mohamed Drug development and industrial pharmacy 43 (9), 1530-1538, 2017 | 26 | 2017 |
| HDAC6 inhibition alleviates CLL-induced T-cell dysfunction and enhances immune checkpoint blockade efficacy in the Eμ-TCL1 model K Maharaj, JJ Powers, M Mediavilla-Varela, SS Jones, E Sahakian Frontiers in Immunology 11, 590072, 2020 | 21 | 2020 |
| Laser-assisted skin delivery of immunocontraceptive rabies nanoparticulate vaccine in poloxamer gel A Bansal, W Gamal, IJ Menon, V Olson, X Wu, MJ D'Souza European Journal of Pharmaceutical Sciences 155, 105560, 2020 | 18 | 2020 |
| Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception A Bansal, W Gamal, X Wu, Y Yang, V Olson, MJ D'Souza Nanomedicine: Nanotechnology, Biology and Medicine 21, 102049, 2019 | 13 | 2019 |
| Development of novel amisulpride-loaded solid self-nanoemulsifying tablets: preparation and pharmacokinetic evaluation in rabbits W Gamal, RH Fahmy, MI Mohamed Drug development and industrial pharmacy 43 (9), 1539-1547, 2017 | 11 | 2017 |
| The role of Th17 cells in chronic lymphocytic leukemia: friend or foe? W Gamal, E Sahakian, J Pinilla-Ibarz Blood Advances 7 (11), 2401-2417, 2023 | 6 | 2023 |
| EHA2024 Hybrid Congress Abstracts HemaSphere 8 (S1), e104, 2024 | | 2024 |
| Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia W Gamal, M Mediavilla-Varela, A Uriepero-Palma, J Pinilla-Ibarz, ... International Journal of Molecular Sciences 25 (12), 6324, 2024 | | 2024 |
| XX International workshop on chronic lymphocytic leukemia Abstracts Leukemia & Lymphoma 64 (sup1), S1–S197, 2023 | | 2023 |
| Characterization of T-cell metabolic defects in chronic lymphocytic leukemia preclinical model W Gamal, M Mediavilla-Varela, K Maharaj, A Uriepero, V Kunta, ... Cancer Research 83 (7_Supplement), 4843-4843, 2023 | | 2023 |
| Targeting Inflammatory Pathways to Reverse Immunosuppressive Tumor Microenvironment in Chronic Lymphocytic Leukemia A Uriepero, M Mediavilla-Varela, K Maharaj, W Gamal, ME Marquez, ... Blood 140 (Supplement 1), 6988-6989, 2022 | | 2022 |
| Metabolic Abnormalities Associated with T-Cell Exhaustion in CLL Eµ-TCL1 Murine Model W Gamal, M Mediavilla-Varela, K Maharaj, A Uriepero, V Kunta, ... Blood 140 (Supplement 1), 6994-6995, 2022 | | 2022 |
| Efficacy and immune profiling of PI3K delta inhibitor zandelisib (ME-401) in a preclinical chronic lymphocytic leukemia (CLL) model K Maharaj, M Mediavilla-Varela, JJ Powers, S Wiley, A Uriepero, ... Cancer Research 82 (12_Supplement), 5496-5496, 2022 | | 2022 |
| Efficacy of Vecabrutinib Treatment in a Murine Model of Sclerodermatous Graft-Versus-Host-Disease K Maharaj, M Mediavilla-Varela, A Uriepero, JA Fox, P Taverna, W Gamal, ... Blood 138, 1685, 2021 | | 2021 |
Eva Sahakian, Ph.DSenior Research Scientist Moffitt cancer center; Assistant Professor USF Morsani School of Medicine在 moffitt.org 的电子邮件经过验证
